1
|
Sağıroğlu AA, Çelik B, Güler EM, Koçyiğit A, Özer Ö. Evaluation of wound healing potential of new composite liposomal films containing coenzyme Q10 and d-panthenyl triacetate as combinational treatment. Pharm Dev Technol 2021; 26:444-454. [PMID: 33583320 DOI: 10.1080/10837450.2021.1887892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Conventional formulations can not achieve wound healing efficiently and fail to accelerate wound regeneration. To overcome these problems, it was planned to develop nanoformulations that perform a positive effect on the wound healing duration and are suitable for topical use. In this study, liposomal film formulations that encapsulated d-panthenyl triacetate (PTA) and coenzyme Q10 (CoQ10) were optimized by using response surface methodology (RSM) and were analyzed for their wound healing efficacy and cytotoxicity on fibroblast (CCD1079 Sk) and keratinocyte (HEKa) cells. Swelling index, puncture strength, and puncture deformation values, which were choosen as dependent variables for the liposomal film formulation were found as 556.9% ± 21.3, 3.98 ± 0.98 N/mm2, and 6.57% ± 1.12, respectively. Cumulative release of 65.32% for PTA and 12.23% for CoQ10 was obtained after 24 hours of in vitro release study in sink conditions. The in vitro cytotoxicity and wound healing assay results suggested that optimum formulation could be used safely on fibroblast and keratinocyte cells and provided wound closure entirely after 24 h. Consequently, the optimum liposomal film containing PTA and CoQ10 formulations could be proposed as an innovative approach in wound healing treatment, considering their release, mechanical properties, stability, and effectiveness.
Collapse
Affiliation(s)
- Ali Asram Sağıroğlu
- Faculty of Pharmacy, Pharmaceutical Technology Department, Bezmialem Vakif University, Istanbul, Turkey
| | - Burak Çelik
- Faculty of Pharmacy, Pharmaceutical Technology Department, Bezmialem Vakif University, Istanbul, Turkey
| | - Eray Metin Güler
- Hamidiye School of Medicine, Department of Medical Biochemistry, University of Health Sciences, Istanbul, Turkey.,Hamidiye Faculty of Medicine, Haydarpasa Numune Health Application and Research Center, Department of Medical Biochemistry, University of Health Sciences, Istanbul, Turkey
| | - Abdurrahim Koçyiğit
- Faculty of Medicine, Medical Biochemistry Department, Bezmialem Vakif University, Istanbul, Turkey
| | - Özgen Özer
- Faculty of Pharmacy, Department of Pharmaceutical Technology, Ege University, Izmir, Turkey
| |
Collapse
|
2
|
Tetik G, Rençber S, Özoglu ET, Yapar EA, Karavana SY, Özer Ö. Design and Evaluation of Topical Antioxidant Nanogel Formulations. J Cosmet Sci 2021; 72:47-62. [PMID: 35349425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Transdermal delivery of an active substance is promising, but a challenging option is available for local and systemic effects. The prolonged residence of formulation in the skin is important for topical delivery. In this study, it was aimed to develop a formulation that can overcome the stability and absorption problems of the vitamin C active substance by preparing nanogels. Nanogel-based materials have high drug loading capacity, biocompatibility, stability, and biodegradability, which are the key points to design a topical drug delivery system. Bovine serum albumin (BSA) and chitosan (CS) were used to prepare nanogels by a simple green self-assembly technique. Prepared nanogels were successfully used to entrap vitamin C, with an entrapment ratio between 86.08% ± 1.29% and 107.93% ± 1.04%. The studies started with vitamin C analysis and continued with characterization studies such as homogeneity, pH, viscosity, rheological properties, zeta potential, polydispersity index, particle size, and in vitro dissolution studies of nanogels. The antioxidant activities of the formulations were also tested by cell culture studies. The antioxidant activities of the nanogels were also tested by in vitro 2,2-diphenyl-1-picrylhydrazyl assay. Although topical vitamin C is effective in many ways, it has a risk of serious stability and absorption problems. The present work was aimed at developing pharmaceutically optimized topical nanogel formulations of vitamin C for antioxidant effect. An optimum nanogel formulation was composed of a 1:4 ratio of CS:BSA with (F19 formulation) in terms of entrapping vitamin C, formulation homogeneity, pH, viscosity, rheological properties, zeta potential, PI, particle size, in vitro dissolution and cell culture studies. The optimized formulation showed higher antioxidant efficacy in vitro than vitamin C. In conclusion, prepared topical nanogel of vitamin C was stable and could be used with promising potential for topical application.
Collapse
Affiliation(s)
- Gökçe Tetik
- Department o f Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir 35100, Turkey (G.K., S.Y.K , Ö.Ö.), Department of Pharmaceutical Technology, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (S.R.), Departm ent of Biochemistry, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (E.T.Ö), Departm ent of Analysis and Control Laboratories, Turkish Medicines and Medical Devices Agency, MoH Turkey, Ankara 06430, Turkey (E.A.Y)
| | - Seda Rençber
- Department o f Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir 35100, Turkey (G.K., S.Y.K , Ö.Ö.), Department of Pharmaceutical Technology, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (S.R.), Departm ent of Biochemistry, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (E.T.Ö), Departm ent of Analysis and Control Laboratories, Turkish Medicines and Medical Devices Agency, MoH Turkey, Ankara 06430, Turkey (E.A.Y)
| | - Ezgi T Özoglu
- Department o f Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir 35100, Turkey (G.K., S.Y.K , Ö.Ö.), Department of Pharmaceutical Technology, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (S.R.), Departm ent of Biochemistry, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (E.T.Ö), Departm ent of Analysis and Control Laboratories, Turkish Medicines and Medical Devices Agency, MoH Turkey, Ankara 06430, Turkey (E.A.Y)
| | - Evren A Yapar
- Department o f Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir 35100, Turkey (G.K., S.Y.K , Ö.Ö.), Department of Pharmaceutical Technology, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (S.R.), Departm ent of Biochemistry, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (E.T.Ö), Departm ent of Analysis and Control Laboratories, Turkish Medicines and Medical Devices Agency, MoH Turkey, Ankara 06430, Turkey (E.A.Y)
| | - Sinem Y Karavana
- Department o f Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir 35100, Turkey (G.K., S.Y.K , Ö.Ö.), Department of Pharmaceutical Technology, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (S.R.), Departm ent of Biochemistry, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (E.T.Ö), Departm ent of Analysis and Control Laboratories, Turkish Medicines and Medical Devices Agency, MoH Turkey, Ankara 06430, Turkey (E.A.Y)
| | - Özgen Özer
- Department o f Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir 35100, Turkey (G.K., S.Y.K , Ö.Ö.), Department of Pharmaceutical Technology, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (S.R.), Departm ent of Biochemistry, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Turkey (E.T.Ö), Departm ent of Analysis and Control Laboratories, Turkish Medicines and Medical Devices Agency, MoH Turkey, Ankara 06430, Turkey (E.A.Y)
| |
Collapse
|
3
|
Azizoğlu E, Özer Ö. Fabrication of Montelukast sodium loaded filaments and 3D printing transdermal patches onto packaging material. Int J Pharm 2020; 587:119588. [PMID: 32663585 DOI: 10.1016/j.ijpharm.2020.119588] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Revised: 06/23/2020] [Accepted: 06/24/2020] [Indexed: 01/16/2023]
Abstract
The main objectives of this work were to develop and characterize new 3D printing filaments and print them directly onto a packaging material. Different blends of polymers were tested to achieve low-temperature printing filaments, which are flexible and durable to be wound onto spools. The mechanical properties of filaments were compared with commercial filaments and evaluated by bending tests. Kollidon 12PF, PEG 4000, and PEO 900k blends resulted in promising filaments that could be extruded at 70 °C and had flexibility similar to commercial PLA filaments. Montelukast sodium (MS), which undergoes hepatic first-pass metabolism, was compounded into polymer blends, and drug-loaded filaments were extruded. All filaments were tested with a 3D printing pen prior to using with the 3D printer for transdermal patches. MS loaded filaments and patches showed similar flexibility with placebo. In vitro drug release studies showed 52% of MS was released in 24 h. Printing on disposable packaging material is presented for the first time with this study. Build plate adhesion and cohesion of 3D printed layers were successfully achieved. This new technique could prevent cross-contamination, save time, and provide ease of use, which can take us one step closer to the production of personalized drugs in pharmacies.
Collapse
Affiliation(s)
- Erkan Azizoğlu
- Ege University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 35040 Bornova, Izmir, Turkey.
| | - Özgen Özer
- Ege University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 35040 Bornova, Izmir, Turkey.
| |
Collapse
|
4
|
Erol İ, Üstündağ Okur N, Orak D, Sipahi H, Aydın A, Özer Ö. Tazarotene-loaded in situ gels for potential management of psoriasis: biocompatibility, anti-inflammatory and analgesic effect. Pharm Dev Technol 2020; 25:909-918. [PMID: 32364036 DOI: 10.1080/10837450.2020.1765180] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Psoriasis is a chronic autoinflammatory disorder characterized by patches of abnormal skin. For psoriasis management, the application of topical retinoids as Tazarotene is recommended. However, Tazarotene could induce skin irritation limiting its use. Herein, it is evaluated the possible usage of in situ gels for tazarotene skin delivery. The topical in situ gels were developed using thermosensitive poloxamers via cold method. They were examined for their appearance, sol-gel temperature, clarity, pH, viscosity, in vitro release, and stability. Their biocompatibility was evaluated by investigating their cytotoxicity and irritation inducing capacity. The possible anti-inflammatory and analgesic activities were determined by measuring the nitric oxide and prostaglandin E2 levels production in LPS-stimulated RAW264.7 murine macrophage cells. It was revealed that the in situ gels had no cytotoxic effect (∼95-100% cell viability) and nor irritation potential (∼97% cell viability), according to the in vitro EpiDerm™ reconstituted skin irritation test. Additionally, the 10% tazarotene-in situ gels showed possible analgesic activity since the production of prostaglandin E2 (PGE2) was decreased. In further, both concentrations of 5% and 10% tazarotene-in situ gels inhibited significantly the nitrite oxide production at 16% and 19%, respectively. Finally, the prepared in situ gels can act as a potential non-irritant alternative option for tazarotene topical skin delivery.
Collapse
Affiliation(s)
- İpek Erol
- Faculty of Pharmacy, Department of Pharmaceutical Technology, Ege University, Izmir, Turkey
| | - Neslihan Üstündağ Okur
- Faculty of Pharmacy, Department of Pharmaceutical Technology, University of Health Sciences, Istanbul, Turkey
| | - Duygu Orak
- Faculty of Pharmacy, Department of Toxicology, Yeditepe University, Istanbul, Turkey.,Faculty of Pharmacy, Drug, Cosmetic and Medical Device Research-Development and Analysis Laboratory, Yeditepe University, Istanbul, Turkey
| | - Hande Sipahi
- Faculty of Pharmacy, Department of Toxicology, Yeditepe University, Istanbul, Turkey
| | - Ahmet Aydın
- Faculty of Pharmacy, Department of Toxicology, Yeditepe University, Istanbul, Turkey
| | - Özgen Özer
- Faculty of Pharmacy, Department of Pharmaceutical Technology, Ege University, Izmir, Turkey
| |
Collapse
|
5
|
Çetinkalp Ş, Gökçe EH, Şimşir I, Tuncay Tanrıverdi S, Doğan F, Biray Avcı Ç, Eroğlu İ, Utku T, Gündüz C, Özer Ö. Comparative Evaluation of Clinical Efficacy and Safety of Collagen Laminin-Based Dermal Matrix Combined With Resveratrol Microparticles (Dermalix) and Standard Wound Care for Diabetic Foot Ulcers. INT J LOW EXTR WOUND 2020. [PMID: 32131656 DOI: 10.1177/1534734620907773.] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
This is an open, prospective, comparative parallel-arm medical device clinical study of Dermalix (Dx) in diabetic foot wounds. Dx is a 3-dimensional collagen-laminin porous-structured dermal matrix prepared and additionally impregnated with resveratrol-loaded hyaluronic acid and dipalmitoylphosphatidylcholine-based microparticles. The aim was to evaluate the efficacy and safety of Dx, an investigational medical device, in Wagner 1 and 2 wounds in comparison to a standard wound care (SWC) that consists of irrigation and cleaning with sterile saline solution. Forty-eight patients were randomized to receive either SWC or SWC + Dx. A 4-week treatment period was followed by a 2-month follow-up without treatment. The wound area measurement, total collagen, vascular epidermal growth factor, tumor necrosis factor, interleukin 1, caspase 3, glutathione, reduced/oxidized glutathione, and lipid peroxidation levels were evaluated. At the end of 4 weeks, the percentage closures of wounds were determined as 57.82% for Dx, and 26.63% for SWC groups. Dx had a significant effect on tumor necrosis factor, caspase 3, and reduced/oxidized glutathione levels. Dx provided 2 times faster wound healing and decreased oxidative stress. Application of Dx in the first phase of wound would help the wound area heal faster with a safe profile.
Collapse
|
6
|
Çetinkalp Ş, Gökçe EH, Şimşir I, Tuncay Tanrıverdi S, Doğan F, Biray Avcı Ç, Eroğlu İ, Utku T, Gündüz C, Özer Ö. Comparative Evaluation of Clinical Efficacy and Safety of Collagen Laminin–Based Dermal Matrix Combined With Resveratrol Microparticles (Dermalix) and Standard Wound Care for Diabetic Foot Ulcers. INT J LOW EXTR WOUND 2020; 20:217-226. [PMID: 32131656 DOI: 10.1177/1534734620907773] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
This is an open, prospective, comparative parallel-arm medical device clinical study of Dermalix (Dx) in diabetic foot wounds. Dx is a 3-dimensional collagen-laminin porous-structured dermal matrix prepared and additionally impregnated with resveratrol-loaded hyaluronic acid and dipalmitoylphosphatidylcholine-based microparticles. The aim was to evaluate the efficacy and safety of Dx, an investigational medical device, in Wagner 1 and 2 wounds in comparison to a standard wound care (SWC) that consists of irrigation and cleaning with sterile saline solution. Forty-eight patients were randomized to receive either SWC or SWC + Dx. A 4-week treatment period was followed by a 2-month follow-up without treatment. The wound area measurement, total collagen, vascular epidermal growth factor, tumor necrosis factor, interleukin 1, caspase 3, glutathione, reduced/oxidized glutathione, and lipid peroxidation levels were evaluated. At the end of 4 weeks, the percentage closures of wounds were determined as 57.82% for Dx, and 26.63% for SWC groups. Dx had a significant effect on tumor necrosis factor, caspase 3, and reduced/oxidized glutathione levels. Dx provided 2 times faster wound healing and decreased oxidative stress. Application of Dx in the first phase of wound would help the wound area heal faster with a safe profile.
Collapse
|
7
|
Aytekin AA, Tuncay Tanrıverdi S, Aydın Köse F, Kart D, Eroğlu İ, Özer Ö. Propolis loaded liposomes: evaluation of antimicrobial and antioxidant activities. J Liposome Res 2019; 30:107-116. [PMID: 30913939 DOI: 10.1080/08982104.2019.1599012] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Propolis, a natural bee product, has both antimicrobial/antifungal and antioxidant characteristics. Active substances having antimicrobial and antifungal effects are used to avoid infections, which develop during long treatment process of chronic wounds. Antioxidant substances protect wound areas against the effect of free radicals and accelerate the healing process. For this purpose, propolis was used to develop topical liposome formulations for wound treatment. Characterization studies (particle size distribution, polydispersity index, Zeta Potential, morphology pH, loading capacity, encapsulation efficiency, in-vitro release behaviour) as well as stability studies were performed. Then in-vitro antioxidant (free radical scavenging capacity and trolox equivalent antioxidant capacity) and antimicrobial/antifungal activities of formulations have been evaluated. The particle size of formulations was found within the range of 300-750 nm depending on the concentration of lipid and water phase in the formulation. The Zeta Potential and pH values of optimum formulation were -23.0 ± 0.666 and 6.34, respectively. Loading capacity and encapsulation efficiency were 66.535 ± 2.705% and 57.321 ± 2.448%. At the end of 8 h, 48.16% of propolis was released and the formulations were found stable during 3 months at +4 °C. Drug loaded liposome formulations significantly scavenged the ABTS+ radical in a dose-dependent manner of propolis when compared with unloaded liposome formulations (p < 0.05). The minimum inhibitory concentration (MIC) values of liposomes ranged from 512 to 128 μg/mL for bacteria and 256 to 128 μg/mL for fungi. Overall results showed that effective and innovative alternative was developed for topical application in wound treatment with propolis loaded liposomal formulations having antioxidant and antimicrobial effects.
Collapse
Affiliation(s)
- Ayşegül Aylin Aytekin
- Faculty of Pharmacy, Department of Pharmaceutical Technology, Ege University, Bornova, Izmir, Turkey
| | - Sakine Tuncay Tanrıverdi
- Faculty of Pharmacy, Department of Pharmaceutical Technology, Ege University, Bornova, Izmir, Turkey
| | - Fadime Aydın Köse
- Faculty of Pharmacy, Department of Biochemistry, Ege University, Bornova, Izmir, Turkey
| | - Didem Kart
- Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Hacettepe University, Ankara, Turkey
| | - İpek Eroğlu
- Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences, Hacettepe University, Ankara, Turkey
| | - Özgen Özer
- Faculty of Pharmacy, Department of Pharmaceutical Technology, Ege University, Bornova, Izmir, Turkey
| |
Collapse
|
8
|
Eren B, Tuncay Tanrıverdi S, Aydın Köse F, Özer Ö. Antioxidant properties evaluation of topical astaxanthin formulations as anti‐aging products. J Cosmet Dermatol 2018; 18:242-250. [DOI: 10.1111/jocd.12665] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/09/2018] [Indexed: 11/30/2022]
Affiliation(s)
- Bilge Eren
- Faculty of Pharmacy Department of Pharmaceutical Technology Ege University IzmirTurkey
| | | | - Fadime Aydın Köse
- Faculty of Pharmacy Department of Biochemistry Ege University Izmir Turkey
| | - Özgen Özer
- Faculty of Pharmacy Department of Pharmaceutical Technology Ege University IzmirTurkey
| |
Collapse
|
9
|
Simsolo EE, Eroğlu İ, Tanrıverdi ST, Özer Ö. Formulation and Evaluation of Organogels Containing Hyaluronan Microparticles for Topical Delivery of Caffeine. AAPS PharmSciTech 2018; 19:1367-1376. [PMID: 29380282 DOI: 10.1208/s12249-018-0955-x] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Accepted: 01/06/2018] [Indexed: 12/14/2022] Open
Abstract
Cellulite is a dermal disorder including the extracellular matrix, the lymphatic and microcirculatory systems and the adipose tissue. Caffeine is used as the active moiety depending its preventive effect on localization of fat in the cellular structure. Hyaluronic acid (hyaluronan-HA) is a natural constituent of skin that generates formation and poliferation of new cells having a remarkable moisturizing ability. The aim of this study is to formulate HA microparticles loaded with caffeine via spray-drying method. Resulting microparticle formulations (33.97 ± 0.3 μm, span < 2, 88.56 ± 0.42% encapsulation efficiency) were distributed in lecithin organogels to maintain the proper viscosity for topical application. Following the characterization and cell culture studies, in vitro drug release and ex vivo permeation studies were performed. The accumulated amount of caffeine was twice higher than the aqueous solution for the microparticle-loaded organogels at 24 h (8262,673 μg/cm2versus 4676,691 μg/cm2). It was related to the sustained behaviour of caffeine release from the microparticles. As a result, lecithin organogel containing HA-encapsulated microparticles could be considered as suitable candidate formulations for efficient topical drug delivery system of caffeine. In addition to that, synergistic effect of this combination appears as a promising approach for long-acting treatment of cellulite.
Collapse
|
10
|
Langasco R, Tanrıverdi ST, Özer Ö, Roldo M, Cossu M, Rassu G, Giunchedi P, Gavini E. Prolonged skin retention of clobetasol propionate by bio-based microemulsions: a potential tool for scalp psoriasis treatment. Drug Dev Ind Pharm 2017; 44:398-406. [PMID: 29098874 DOI: 10.1080/03639045.2017.1395458] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Novel effective and cosmetically acceptable formulations are needed for the treatment of scalp psoriasis, due to the poor efficacy of the current products. The challenge in developing safe, efficient, and convenient delivery systems for this drug was addressed in the present work by formulating clobetasol propionate-loaded W/O microemulsions (MEs). Pseudo-ternary phase diagrams were constructed by using a combination of biocompatible and biodegradable excipients. Characterization studies demonstrated that selected MEs had suitable technological features such as being Newtonian fluids, possessing low viscosity, and high thermodynamic stability. Photomicrographs showed a significant alteration of the skin structure after treatment with MEs, and a preferential concentration of these in the stratum corneum and epidermis. These data, together with ex vivo permeation results, suggested an enhanced topical targeted effect due to an increased drug retention efficacy in the upper skin layers, as desired. Moreover, the bio-based excipients selected could contribute to the healing of the psoriatic scalp. In this way, the improvement of clobetasol efficacy is combined with the useful properties of the microemulsion components and with environmental safety.
Collapse
Affiliation(s)
- Rita Langasco
- a Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Sakine Tuncay Tanrıverdi
- b Department of Pharmaceutical Technology, Faculty of Pharmacy , Ege University , Izmir , Turkey
| | - Özgen Özer
- b Department of Pharmaceutical Technology, Faculty of Pharmacy , Ege University , Izmir , Turkey
| | - Marta Roldo
- c School of Pharmacy and Biomedical Sciences , University of Portsmouth , Portsmouth , UK
| | - Massimo Cossu
- a Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Giovanna Rassu
- a Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Paolo Giunchedi
- a Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Elisabetta Gavini
- a Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| |
Collapse
|
11
|
Abstract
Melatonin-loaded hyaluronic acid (HA) and poly(vinyl alcohol) (PVA) gels were prepared by using freeze-thaw technique and an emulsion method followed by freeze-thaw technique to produce a new synergistic system for topical application. Freeze-thaw hydrogels and emulgels were characterized by means of Fourier transform infrared spectroscopy, rheology and swelling tests. The porous structure of the hydrogels was shown by scanning electron microscopy observations and thermal properties were tested by differential scanning calorimetry measurements. Bioadhesion and in vitro release characterization of formulations were performed by texture profile analysis and dialysis bag method, respectively. The pore size of both formulations was ranging from 900 nm to 30 μm. Melatonin showed a good compatibility with the polymeric matrices as the pores were smaller for the drug-loaded systems. In vitro release studies showed that the release was improved by emulgel formulations. After 24 h, the release percentage was found to be 13.240% ± 1.094 and 15.192% ± 2.270 for hydrogel and emulgel, respectively. Emulgels had better bioadhesion properties than simple freeze-thaw samples. As a conclusion, regarding the in vitro characterization studies HA and PVA hydrogel and emulgel formulations and their lyophilized forms could be promising systems for topical application of melatonin.
Collapse
Affiliation(s)
- Sakine Tuncay Tanrıverdi
- a Department of Pharmaceutical Technology, Faculty of Pharmacy , Ege University , Bornova-İzmir , Turkey
| | - Catalina Natalia Cheaburu-Yilmaz
- a Department of Pharmaceutical Technology, Faculty of Pharmacy , Ege University , Bornova-İzmir , Turkey.,b Department of Physical Chemistry of Polymers , "Petru Poni" Institute of Macromolecular Chemistry , Iasi , Romania
| | - Sonia Carbone
- c Faculty of Pharmacy , University of Turin , Torino , Italy
| | - Özgen Özer
- a Department of Pharmaceutical Technology, Faculty of Pharmacy , Ege University , Bornova-İzmir , Turkey
| |
Collapse
|
12
|
Langasco R, Spada G, Tanriverdi ST, Rassu G, Giunchedi P, Özer Ö, Gavini E. Bio-based topical system for enhanced salicylic acid delivery: preparation and performance of gels. J Pharm Pharmacol 2016; 68:999-1009. [DOI: 10.1111/jphp.12582] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2016] [Accepted: 05/14/2016] [Indexed: 12/14/2022]
Abstract
Abstract
Objectives
New salicylic acid (SA)-loaded gels were developed using excipients made from renewable materials, and our goal was to improve drug permeation in the topical treatment of acne vulgaris.
Methods
We studied the preparation parameters to obtain suitable gel formulations. Only naturally occurring polymers were used as gelling agents. Two hydrogels and three lipogels were selected and characterized in terms of drug loading, pH, viability cells, rheology, mechanical properties and in vitro permeation; these hydrogels and lipogels were compared with the traditional ointment. We also evaluated skin parameters before and after gel application.
Key findings
The formulations that we studied are non-Newtonian fluids; they have high drug loading and suitable mechanical properties. Lipogels exhibit a slower and more linear in vitro permeation profile compared with hydrogels. The different vehicles that we used affected drug permeation and improve patient compliance. Cytotoxicity studies suggest that all of the formulations are non-toxic.
Conclusions
Lipogels demonstrate appropriate technological features and improved performance compared with the traditional ointment with regard to their composition. Lipogels may represent a new bio-based topical system for SA delivery. The use of ‘green’ excipients leads to ‘skin-friendly’ formulations that are able to satisfy environmental safety.
Collapse
Affiliation(s)
- Rita Langasco
- Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy
| | | | | | - Giovanna Rassu
- Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy
| | - Paolo Giunchedi
- Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy
| | - Özgen Özer
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir, Turkey
| | - Elisabetta Gavini
- Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy
| |
Collapse
|
13
|
Tuncay Tanrıverdi S, Hilmioğlu Polat S, Yeşim Metin D, Kandiloğlu G, Özer Ö. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis:in vitroandin vivoevaluation. J Liposome Res 2015; 26:163-73. [DOI: 10.3109/08982104.2015.1067892] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
14
|
Üstündağ-Okur N, Gökçe EH, Bozbıyık Dİ, Eğrilmez S, Ertan G, Özer Ö. Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis. Expert Opin Drug Deliv 2015; 12:1791-807. [DOI: 10.1517/17425247.2015.1059419] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
15
|
Eroğlu İ, Gökçe EH, Tsapis N, Tanrıverdi ST, Gökçe G, Fattal E, Özer Ö. Evaluation of characteristics and in vitro antioxidant properties of RSV loaded hyaluronic acid-DPPC microparticles as a wound healing system. Colloids Surf B Biointerfaces 2014; 126:50-7. [PMID: 25543983 DOI: 10.1016/j.colsurfb.2014.12.006] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2014] [Revised: 11/04/2014] [Accepted: 12/04/2014] [Indexed: 11/29/2022]
Abstract
Resveratrol (RSV) was incorporated into microparticles by spray drying to treat chronic wounds such as diabetic ulcers. RSV was chosen due to its defense mechanisms as the formation of free radicals delays the healing process. RSV was loaded into microparticles consisting of dipalmitoylphosphatidylcholine (DPPC) and hyaluronic acid (HA), a polysaccharide naturally present within the skin, known to contribute to the healing process. Microparticles were evaluated in terms of production yield, size distribution, encapsulation efficiency, morphology, specific surface area, thermal properties and water content. Spherical and homogenous microparticles (span ≤ 2) in a size range between 20 and 30 μm were obtained with high encapsulation efficiency (≥ 97%). The effect of enzymes (hyaluronidase, phospholipase and lipase) on RSV release showed a dose-dependent pattern followed by a slow release stage. Cytotoxicity/proliferation and oxidative stress parameters (glutathione, oxidized glutathione, glutathione peroxidase, malondialdehyde, superoxide dismutase) obtained from human dermal fibroblast cell cultures revealed that formulations increased cell proliferation and the presence of RSV decreased oxidation in cells. RSV-loaded HA-DPPC microparticles appear as a promising formulation for wound healing due to synergistic effect of the ingredients.
Collapse
Affiliation(s)
- İpek Eroğlu
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ege, Izmir, 35100, Turkey
| | - Evren H Gökçe
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ege, Izmir, 35100, Turkey
| | - Nicolas Tsapis
- Université Paris-Sud, Institut Galien Paris-Sud, UMR CNRS 8612, Faculté de Pharmacie, Rue JB Clément, 92296, Châtenay-Malabry, France
| | - Sakine Tuncay Tanrıverdi
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ege, Izmir, 35100, Turkey
| | - Göksel Gökçe
- Department of Pharmacology, Faculty of Pharmacy, University of Ege, Izmir, 35100, Turkey
| | - Elias Fattal
- Université Paris-Sud, Institut Galien Paris-Sud, UMR CNRS 8612, Faculté de Pharmacie, Rue JB Clément, 92296, Châtenay-Malabry, France
| | - Özgen Özer
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ege, Izmir, 35100, Turkey.
| |
Collapse
|
16
|
Eroğlu İ, Azizoğlu E, Özyazıcı M, Nenni M, Gürer Orhan H, Özbal S, Tekmen I, Ertam İ, Ünal İ, Özer Ö. Effective topical delivery systems for corticosteroids: dermatological and histological evaluations. Drug Deliv 2014; 23:1502-13. [PMID: 25259424 DOI: 10.3109/10717544.2014.960981] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Atopic dermatitis (AD) is a chronic and relapsing skin disease with severe eczematous lesions. Long-term topical corticosteroid treatment can induce skin atrophy, hypopigmentation and transepidermal water loss (TEWL) increase. A new treatment approach was needed to reduce the risk by dermal targeting. For this purpose, Betamethasone valerate (BMV)/Diflucortolone valerate (DFV)-loaded liposomes (220-350 nm) were prepared and incorporated into chitosan gel to obtain adequate viscosity (∼13 000 cps). Drugs were localized in stratum corneum + epidermis of rat skin in ex-vivo permeation studies. The toxicity was assessed on human fibroblast cells. In point of in-vivo studies, pharmacodynamic responses, treatment efficacy and skin irritation were evaluated and compared with previously prepared nanoparticles. Liposome/nanoparticle in gel formulations produced higher paw edema inhibition in rats with respect to the commercial cream. Similar skin blanching effect with commercial creams was obtained via liposome in gels although they contain 10 times less drug. Dermatological scoring results, prognostic histological parameters and suppression of mast cell numbers showed higher treatment efficiency of liposome/nanoparticle in gel formulations in AD-induced rats. TEWL and erythema measurements confirmed these results. Overview of obtained results showed that liposomes might be an effective and safe carrier for corticosteroids in skin disease treatment.
Collapse
Affiliation(s)
| | | | | | - Merve Nenni
- b Department of Pharmaceutical Toxicology, Faculty of Pharmacy , Ege University , Bornova, Izmir , Turkey
| | - Hande Gürer Orhan
- b Department of Pharmaceutical Toxicology, Faculty of Pharmacy , Ege University , Bornova, Izmir , Turkey
| | - Seda Özbal
- c Department of Histology and Embryology, Faculty of Medicine , Dokuz Eylul University , Inciralti, Izmir , Turkey , and
| | - Işıl Tekmen
- c Department of Histology and Embryology, Faculty of Medicine , Dokuz Eylul University , Inciralti, Izmir , Turkey , and
| | - İlgen Ertam
- d Department of Dermatology, Faculty of Medicine , Ege University , Bornova, Izmir , Turkey
| | - İdil Ünal
- d Department of Dermatology, Faculty of Medicine , Ege University , Bornova, Izmir , Turkey
| | - Özgen Özer
- a Department of Pharmaceutical Technology
| |
Collapse
|
17
|
Üstündag-Okur N, Gökçe EH, Eğrilmez S, Özer Ö, Ertan G. Novel Ofloxacin-Loaded Microemulsion Formulations for Ocular Delivery. J Ocul Pharmacol Ther 2014; 30:319-32. [DOI: 10.1089/jop.2013.0114] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Neslihan Üstündag-Okur
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ege, Izmir, Turkey
| | - Evren Homan Gökçe
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ege, Izmir, Turkey
| | - Sait Eğrilmez
- Department of Ophthalmology, School of Medicine, University of Ege, Izmir, Turkey
| | - Özgen Özer
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ege, Izmir, Turkey
| | - Gökhan Ertan
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ege, Izmir, Turkey
| |
Collapse
|
18
|
Biray Avcı Ç, Özcan İ, Balcı T, Özer Ö, Gündüz C. Design of polyethylene glycol-polyethylenimine nanocomplexes as non-viral carriers: mir-150 delivery to chronic myeloid leukemia cells. Cell Biol Int 2013; 37:1205-14. [PMID: 23881828 DOI: 10.1002/cbin.10157] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2013] [Accepted: 07/01/2013] [Indexed: 12/17/2022]
Abstract
MicroRNAs (miRNAs) are acknowledged as indispensable regulators relevant in many biological processes, and they have been pioneered as therapeutic targets for curing disease. miRNAs are single-stranded, small (19-22 nt) regulatory non-coding RNAs whose deregulation of expression triggers human cancers, including leukemias, mainly through dysregulation of expression of leukemia genes. miRNAs can function as tumour suppressors (suppressing malignant potential) or oncogenes (activating malignant potential) like actors of complex diseases. To address the issue of overcoming instability and low transfection efficiency in vitro, the polyethylene glycol-polyethyleneimine (PEG-PEI) nanoparticle was used as non-viral vector carrier for miR-150 transfection, which is downregulated in chronic myeloid leukemia. PEG-PEI [PEG(550)3 -g-PEI(1800) ]/miRNA nanocomplexes were synthesised and characterised by particle size distribution (PSD), polydispersity index (PDI) and zeta potential, surface charge, their cytotoxicity, and transfection efficiency. Interaction with human leukemia cells (K-562 and KU812) and control cells NCI-BL2347 with them has been investigated. The transfection efficiency of PEG-PEI/miRNA at N/P 26 rose 6.7-fold above the control by qRT-PCR. The size of homogenous nanocomplexes (PBI < 0.5) was 160.8 ± 11 nm. The data indicate that PEG-PEI may be an encouraging non-viral carrier for altering miRNA expression in the treatment of chronic myeloid leukemia, with many advantages such as relatively high miRNA transfection efficiency and low cytotoxicity.
Collapse
Affiliation(s)
- Çığır Biray Avcı
- Faculty of Medicine, Department of Medical Biology, Ege University, Bornova, Izmir, Turkey
| | | | | | | | | |
Collapse
|
19
|
|
20
|
Gökçe EH, Yurdasiper A, Korkmaz E, Özer Ö. A novel preparation method for organogels: high-speed homogenization and micro-irradiation. AAPS PharmSciTech 2013; 14:391-7. [PMID: 23344854 DOI: 10.1208/s12249-013-9922-8] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2012] [Accepted: 01/07/2013] [Indexed: 11/30/2022] Open
Abstract
The aim of this work was to prepare organogels of Carbopol 974P NF (C974) in PEG 400 by using a novel technique, high-speed homogenization followed by microwave heating. Triclosan (TCS) was used as a model drug. C974, at concentrations ranging between 2% and 4%, was dispersed in 25 ml of PEG 400, and the dispersion was homogenised for 5 min at 24,000 rpm. The dispersion was either heated at 80°C in water bath under mechanic stirring at 200 rpm or exposed to micro-irradiation (1,200 W/1 h) for 2 min. The formulations prepared with both methods performed a well-structured gel matrix characteristic at 3% and 4% of C974 concentrations. As the concentrations of the polymer increased, the elastic properties also increased. The viscosity profiles indicated a shear-thinning system. DSC data revealed that TCS was dissolved in gel. Skin accumulation ability of TCS had been improved by these novel organogels regardless of the preparation method. TCS was still microbiologically effective after the microwave process was applied. It was determined that microwave heating is a suitable method to obtain C974 organogels. This novel production technique developed might be promising especially in industrial scale when the dramatic reduction in the preparation time and energy were considered.
Collapse
|
21
|
Özcan I, Azizoğlu E, Senyiğit T, Özyazici M, Özer Ö. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate. J Drug Target 2013; 21:542-50. [PMID: 23390922 DOI: 10.3109/1061186x.2013.769106] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Poly(lactide-co-glycolide) (PLGA) and lecithin/chitosan (LC) nanoparticles were prepared to evaluate the difference in the behavior upon administration on skin, for steroidal treatment. For this purpose, betamethasone-17-valerate (BMV)-loaded nanoparticles with a narrow size distribution and high entrapment efficiency were prepared. Permeation studies showed that both polymeric nanoparticles enhanced the amount of BMV in epidermis, which is the target site of topical steroidal treatment, when compared with commercial formulation. 1.58-Fold increase was determined in the epidermis concentration of BMV by LC nanoparticles with respect to PLGA nanoparticles. Nanoparticles were diluted in chitosan gel (10%, w/w) to prepare suitable formulation for topical application. Accumulation from both gel formulations were found significantly higher than commercial formulation in skin layers (p < 0.05). In addition, pharmacodynamic responses were also investigated as anti-inflammatory and skin-blanching parameters. Both formulations significantly improved these parameters although they contained 10 times less amount of BMV than commercial cream. Moreover, TEWL measurement exhibited no barrier function changes upon the application of nanoparticles on skin. Overall, both nanoparticles improved the localization of BMV within skin layers; but when compared with PLGA nanoparticles, the LC nanoparticles could be classified as a better candidate for topical delivery vehicle in the treatment of various dermatological inflammatory diseases.
Collapse
Affiliation(s)
- Ipek Özcan
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Bornova, Izmir-Turkey
| | | | | | | | | |
Collapse
|
22
|
Özcan I, Azizoğlu E, Senyiğit T, Özyazıcı M, Özer Ö. Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations. Int J Nanomedicine 2013; 8:461-75. [PMID: 23390364 PMCID: PMC3564463 DOI: 10.2147/ijn.s40519] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The objective of this study was to prepare a suitable formulation for dermal delivery of diflucortolone valerate (DFV) that would maintain the localization in skin layers without any penetration and to optimize efficiency of DFV. Drug-loaded lecithin/chitosan nanoparticles with high entrapment efficiency (86.8%), were successfully prepared by ionic interaction technique. Sustained release of DFV was achieved without any initial burst release. Nanoparticles were also incorporated into chitosan gel at different ratios for preparing a more suitable formulation for topical drug delivery with adequate viscosity. In ex-vivo permeation studies, nanoparticles increased the accumulation of DFV especially in the stratum corneum + epidermis of rat skin without any significant permeation. Retention of DFV from nanoparticle in chitosan gel formulation (0.01%) was twofold higher than commercial cream, although it contained ten times less DFV. Nanoparticles in gel formulations produced significantly higher edema inhibition in rats compared with commercial cream in in-vivo studies. Skin blanching assay using a chromameter showed vasoconstriction similar to that of the commercial product. There were no barrier function changes upon application of nanoparticles. In-vitro and in-vivo results demonstrated that lecithin/chitosan nanoparticles in chitosan gel may be a promising carrier for dermal delivery of DFV in various skin disorders.
Collapse
Affiliation(s)
- Ipek Özcan
- Ege University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Bornova, Izmir, Turkey.
| | | | | | | | | |
Collapse
|
23
|
Tanrıverdi ST, Özer Ö. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis. Eur J Pharm Sci 2013; 48:628-36. [PMID: 23295582 DOI: 10.1016/j.ejps.2012.12.014] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2012] [Revised: 12/12/2012] [Accepted: 12/20/2012] [Indexed: 10/27/2022]
Abstract
Terbinafine hydrochloride (TBF-HCl) is an active substance that is using for treatment of onychomycosis. Onychomycosis is a fungal infection which is the most common disease of nail plate. The nail plate is a barrier which prevents effective topical treatment of ungual disorders. In this study, TBF-HCl loaded liposome and ethosome formulations and also gel form of these formulations were prepared. The formulations were characterized and in vitro and ex vivo release studies were performed. Nail characterization studies were also performed to examine the effect of formulations and experimental conditions on nail surface. As a result, all formulations can serve as efficient formulations for ungual application of TBF-HCl. By the way, the results of the accumulation studies suggested that liposome poloxamer gel formulation could be promising system for ungual drug delivery due to the better accumulation and easier application of the formulation.
Collapse
Affiliation(s)
- Sakine Tuncay Tanrıverdi
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, 35100 Bornova, Izmir, Turkey.
| | | |
Collapse
|
24
|
Aksu B, Paradkar A, de Matas M, Özer Ö, Güneri T, York P. A quality by design approach using artificial intelligence techniques to control the critical quality attributes of ramipril tablets manufactured by wet granulation. Pharm Dev Technol 2012; 18:236-45. [DOI: 10.3109/10837450.2012.705294] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
25
|
Şenyiğit T, Sonvico F, Barbieri S, Özer Ö, Santi P, Colombo P. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Control Release 2010; 142:368-73. [DOI: 10.1016/j.jconrel.2009.11.013] [Citation(s) in RCA: 118] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2009] [Revised: 11/10/2009] [Accepted: 11/15/2009] [Indexed: 11/30/2022]
|
26
|
Şenyiğit T, Padula C, Özer Ö, Santi P. Different approaches for improving skin accumulation of topical corticosteroids. Int J Pharm 2009; 380:155-60. [DOI: 10.1016/j.ijpharm.2009.07.018] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2009] [Revised: 07/10/2009] [Accepted: 07/17/2009] [Indexed: 10/20/2022]
|
27
|
Özcan İ, Abacı Ö, Uztan AH, Aksu B, Boyacıoğlu H, Güneri T, Özer Ö. Enhanced topical delivery of terbinafine hydrochloride with chitosan hydrogels. AAPS PharmSciTech 2009; 10:1024-31. [PMID: 19662536 DOI: 10.1208/s12249-009-9299-x] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2009] [Accepted: 07/27/2009] [Indexed: 11/30/2022] Open
Abstract
Chitosan-based carriers have important potential applications for the administration of drugs. In the present study, topical gel formulations of terbinafine hydrochloride (T-HCl) were prepared using different types of chitosan at different molecular weight, and the antifungal inhibitory activity was evaluated to suggest an effective formulation for the treatment of fungal infections. The characteristics of gel formulations were determined with viscosity measurements and texture profile analysis. Stability studies were performed at different temperatures during 3 months. The ex vivo permeation properties were studied through rat skin by using Franz diffusion cells. The antifungal inhibitory activity of formulations on Candida species and filamentous fungi was also examined with agar-cup method. The microbiological assay was found suitable for determination of in vitro antifungal activity of T-HCl. A marketed product was used to compare the results. The antifungal activity of T-HCl significantly increased when it was introduced into the chitosan gels. A higher drug release and the highest zone of inhibition were obtained from gels prepared with the lowest molecular weight chitosan (Protasan UP CL 213) compared to that of other chitosan gels and marketed product. These results indicated the advantages of the suggested formulations for topical antifungal therapy against Candida species and filamentous fungi.
Collapse
|
28
|
|
29
|
Şenyiğit T, Özer Ö, Güneri T. Enhancement of Betamethasone-17-Valerate release through cellulose acetate membrane using terpenes. Eur J Pharm Sci 2007. [DOI: 10.1016/j.ejps.2007.05.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
|
31
|
Özer Ö, Baloglu E, Ertan G, Muguet V, Yazan Y. The effect of the type and the concentration of the lipophilic surfactant on the stability and release kinetics of the W/O/W multiple emulsions. Int J Cosmet Sci 2000. [DOI: 10.1111/j.1468-2494.2000.00049.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|